Mesenchymal stem cells (MSCs) can ameliorate myocardial infarction (MI) injury. However, older-donor MSCs seem less efficacious than those from younger donors, and the contributing underlying mechanisms remain unknown. Here, we determine how age-related expression of pigment epithelium-derived factor (PEDF) affects MSC therapeutic efficacy for MI.
Introduction
Myocardial infarction (MI) remains the most common cause of cardiac morbidity and mortality in the developed world. Acute myocardial ischaemia causes rapid death of cardiomyocytes and vasculature, leading to left ventricular (LV) remodelling, including progressive fibrotic myocardium replacement, LV dilation, and heart failure. 1 In the last decade, stem cell therapy has been shown to be a promising method for treating MI, 2 and mesenchymal stem cells (MSCs) have been considered a good option because of their unique biological attributes. 3, 4 When introduced to an infarcted heart, MSCs prevent deleterious remodelling and improve recovery. 3, 4 Increasing evidence demonstrates that the beneficial effect of MSCs is significantly mediated through incompletely understood indirect paracrine actions, 4 -8 supplying multiple therapeutic growth factors and cytokines regulatory of the ongoing MI pathological processes. 4 -6 In recent studies, pigment epithelium-derived factor (PEDF), a member of the serpin protease inhibitor family lacking protease inhibitory activity, was identified as a major MSC-secreted protein. 9, 10 Pigment epithelium-derived factor is a multifunctional, pleiotropic protein with antiangiogenic, antioxidant, anti-inflammatory, anti-tumourigenic, and neuroprotective properties, with cell-type-dependent biological function. 11 Thus, PEDF might be contributive to MSC paracrine actions regulating ongoing MI pathologic processes, but has not been investigated. Most clinical studies have used autologous stem cells for MI treatment. Patients suffering MI typically are of advanced age. However, the impact of donor age on MSCs therapeutic efficacy remains uncertain. 12 Clarification of this issue and underlying mechanisms are of utmost importance, as their elucidation will give insight regarding MSC genetic modification with age and any potential reversibility. In the present study, MSCs from older mice secreted significantly greater PEDF levels compared to young mice. We hypothesized that PEDF plays a critical role in MSC paracrine functioning during the pathological processes associated with MI. Furthermore, age-related PEDF expression may critically influence MSC therapeutic efficacy in MI treatment.
Methods
Detailed methodology is available in the Online Data Supplement.
Laboratory animals, isolation, culture, and characterization of mesenchymal stem cells
All experimental animal procedures were approved by the Animal Experiment Administration Committee of our institution. Mesenchymal stem cells were isolated and expanded from young (8-week-old) and older (18-month-old) male C57BL/6 mice via standard protocols. 13 Third-passage cells were used for experiments. To validate the enriched MSCs population, flow cytometry characterized the surface antigens, and in vitro differentiation of cultured MSCs was performed as previously reported.
13
Detection of pigment epithelium-derived factor expression in vitro
Reverse transcriptase -polymerized chain reaction (RT -PCR) analysis was performed as previously described. 9 Pigment epithelium-derived 
Adenoviral vectors and mesenchymal stem cells transduction
Briefly, human type 5 adenoviral vectors (SinoGenoMax Co., Ltd, Beijing, China) expressing human-PEDF (Ad.PEDF) from a cytomegalovirus (CMV) immediate early promoter were generated, and the E1 and E3 regions of the viral genome were replaced with a reporter gene [green fluorescent protein (GFP)]. Control vectors (Ad.Null) not expressing PEDF were constructed and produced concomitantly. In addition, the Ad.shPEDF vector, in which a shRNA was driven by the U6 promoter, and GFP was driven by an independent CMV promoter, which resulted in dramatically attenuated PEDF levels, was generated for further experiments. Ad.shctrl (Ad-Scramble) vector served as a control. Mesenchymal stem cells were incubated with adenoviruses at infection multiplicity of 3000 for 2 h. Transduction efficiency was analysed 24 h after transduction by flow cytometry and inverted microscopy.
Model of myocardial infarction and mesenchymal stem cells transplantation
Myocardial infarction was established as described previously.
14 Briefly,
8-week-old male C57BL/6 mice (under general anesthaesia, with 2% isoflurane) were subjected to small left thoracotomy, temporary cardio-exteriorization, and placement of 6.0 silk suture below origin of the left anterior descending coronary artery (LAD). The heart was replaced immediately into the thoracic cavity, with thoracic air evacuation to avoid pneumothorax. 4.0 × 10 6 MSCs/mouse were tailvein injected 0. ). Cardiac fibroblast proliferation was evaluated 48 h after co-culture under hypoxia using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. Cardiac fibroblast migration assay was carried out using a transwell insert of 8 mm pore size. Chemotaxis was induced by MSCs in the lower compartment. Cardiac fibroblasts were serum-starved overnight, and 5 × 10 4 cells were seeded in the upper compartment. Cells were allowed to migrate for 8 h under hypoxic conditions. The filters were stained with crystal violet for microscopy. A blinded, single person counted the number of cells that migrated to the lower filter surface.
The direct effects of pigment epithelium-derived factor on cardiac fibroblasts Cardiac fibroblasts were stimulated for 8 h with 0 -200 ng/mL recombinant human (rh) PEDF (Peprotech Inc., Rocky Hill, NJ, USA) under hypoxia, and the MTT assay was performed. Cell cycle distribution was detected by a Calibur flow cytometer (Becton -Dickinson, San Jose, CA, USA). For western blotting analysis, 50 mg total proteins from each cell extract was resolved with sodium dodecyl sulfate-polyacrilamide gel electrophoresis and transferred onto a polyvinylidence difluoride membrane (Immobillon-P; Millipore). The membrane was then incubated sequentially with primary anti-cyclin D1, anti-p27, or anti-glyceraldehyde-3-phosphate dehydrogenase (Santa Cruz Biotechnology, Inc.) and horseradish peroxidase-conjugated secondary antibodies; bands were detected with enhanced chemiluminescence (Pierce, Rockford, IL, USA). The CF migration assay was carried out using a transwell insert as described above, except that rh-PEDF was used for chemotaxis in the lower compartment. AnnexinV-FITC apoptosis detection kit (Beckman Coulter, Fullerton, CA, USA) determined apoptotic cell percentage, and flow cytometry analysis (BD Biosciences, San Diego, CA, USA) was performed. Moreover, CFs were stained with Hoechst 33258. Apoptotic CFs were identified on the basis of their nuclear morphology (presence of condensed chromatin and fragmentation). The nuclei from five random fields were counted by a single blinded person, and the percentage of apoptotic nuclei relative to total nuclei was calculated.
Statistical analyses
Data were expressed as mean + standard error of the mean (SEM). Multiple group comparisons were evaluated via one-way analysis of variance followed by least significant difference -t-test for post hoc analysis. Comparisons between two independent groups were analysed using the Student t-test. Analyses were performed using SPSS software, Chicago, IL, USA. P values less than 0.05 were considered to be statistically significant and tests were performed two sided.
Results
Mesenchymal stem cells from older donors express and secrete more pigment epithelium-derived factor than younger donors After three passages, MSC pluripotency was confirmed by capacity to differentiate into adipogenic and osteogenic lineages in vitro ( Figure 1A) . By flow cytometry analysis, cultured MSCs expressed CD29, CD44, CD73, CD90, and CD105, and were devoid of haematopoietic markers CD11b, CD34, and CD45 (Supplementary material online, Table S1 ). Notably, RT-PCR ( Figure 1B ) and ELISA ( Figure 1C ) revealed that, in comparison to young MSCs, significantly greater PEDF expression (for both mRNA and protein levels) was found in older MSCs under both normoxic and hypoxic conditions. Adenoviral vector-transduced mesenchymal stem cells recruit to the infarct region, and regulate pigment epithelium-derived factor levels
We used adenoviral vectors carrying human-PEDF and or short hairpin RNA (shRNA) targeting mouse-PEDF to overexpress PEDF in young MSCs or knock down PEDF expression in older MSCs respectively. All adenoviral vectors were designed to carry a GFP reporter. The transduction efficiency of these adenoviral vectors was analysed (Supplemental Results). Utilizing our mouse MI model, we intravenously injected either: (i) saline, (ii) young MSCs, (iii) old MSCs, (iv) Y&Ad.Null, (v) Y&Ad.PEDF, (vi) O&Ad.shctrl, or (vii) O&Ad.shPEDF. On Day 1 after MI, a large number of GFP positive cells were found dispersed in the infarct region (Figure 2A and B) . Furthermore, no significant differences were observed in the green fluorescent intensity of infarcted hearts among Y&Ad.Null, Y&Ad.PEDF, O&Ad.shctrl, and O&Ad.shPEDF groups ( Figure 2C ), indicating similar numbers of MSCs dispersal in the infarct region among these groups. Subsequently, we performed immunofluorescent staining and ELISA to identify the ability of genetically modified MSCs in the infarct region to regulate local PEDF levels. Greater PEDF levels were found in the infarct region after administration of MSCs of older compared to young origin. Adenoviral vectors were used to overexpress human-PEDF or block mouse-PEDF expression in young or old MSCs in vivo, respectively, thereby leading to PEDF level significantly changes in the infarct region (Supplemental Results).
Decreased efficacy of old mesenchymal stem cells for myocardial infarction treatment is associated with increased pigment epithelium-derived factor expression In order to study whether different PEDF levels could affect the efficacy of MSCs for MI, we performed gross cardiac morphology Expression of pigment epithelium-derived factor in aged mesenchymal stem cells and function analyses. As illustrated in Figure 3A , compared to saline treatment, both young and old MSCs significantly attenuated fibrosis post-MI, but to greater extent after young MSC treatment. Compared to saline treatment, administration of young MSCs after MI markedly improved LV functional parameters. Compared to young MSC treatment, administration of old MSCs after MI increased the ratio of the pre-ejection period/left ventricular ejection time ( Figure 3B ) and LV enddiastolic pressure ( Figure 3D) , and decreased maximum LV pressure ( Figure 3C) , as well as the + dp/dt and -dp/dt ( Figure 3E and F ), all data suggestive of decreased therapeutic ability of old MSCs compared to young MSCs. Importantly, compared with Y&Ad.Null cells, Y&Ad.PEDF not only significantly increased LV fibrosis ( Figure 3A) , but also impaired LV function ( Figure 3B-F) . In contrast, O&Ad.shPEDF decreased the LV fibrosis area ( Figure 3A) , and ameliorated LV function compared with old MSCs transduced with Ad.shctrl ( Figure 3B-F) , supporting the notion that impaired therapeutic efficacy of old MSCs is associated with increased PEDF secretion.
Mesenchymal stem cells regulate the cellular profile in the myocardial infarction area via paracrine factor pigment epithelium-derived factor
To investigate in the underlying mechanism contributing to agediminished efficacy against MI injury, we analysed the cellular profile of the infarct region after administration of saline, young MSCs, or old MSCs. In infarcted myocardial sample regions Figures 4A and 5D) . The infarct area of hearts subjected to old MSCs contained significantly fewer ECs, VSMCs, and macrophages, but more fibroblasts compared to those subjected to young MSCs ( Figures 4A and 5D ). To investigate whether the differential cellular profile between young and old MSCs was caused by variant PEDF level expression, we assessed the resultant cellular profile following administration of genetically modified MSCs. Interestingly, we observed only a small proportion of ECs, fibroblasts, VSMCs, and macrophages in the infarct The effect of pigment epithelium-derived factor on cardiac fibroblast migration. Representative crystal violet staining of migrated cardiac fibroblasts in the lower compartments of the transwell system and bar graph illustrating the effect of pigment epithelium-derived factor on cardiac fibroblasts migration in transwell system. All data expressed as means + SEM. n ¼ 6 per group. *P , 0.05, **P , 0.01, ***P ≤ 0.001.
Expression of pigment epithelium-derived factor in aged mesenchymal stem cells region of hearts receiving CD31-, vimentin-, aSMA-, or F4/80-cells (each with GFP double positivity, confirmatory of viral infectivity, Figures 4E and 5H) . Importantly, PEDF overexpression in young MSCs (Y&Ad.PEDF group vs Y&Ad.Null group) not only decreased the total number of ECs, VSMCs, and macrophages (total CD31-or aSMA-or F4/80-positive cells), but also the number of MSC-derived ECs, VSMCs, and macrophages in the infarct region, whereas both fibroblast (all vimentin-positive cells) and MSC-derived fibroblast populations were increased ( Figures 4E and 5H) . Furthermore, knocking down PEDF expression in old MSCs (O&Ad.shPEDF group vs. O&Ad.shctrl group) increased the total number of ECs, VSMCs, and macrophages, as well as MSC-derived ECs, VSMCs, and macrophages in the infarct region, whereas both fibroblast population and MSC-derived fibroblast density was decreased ( Figures 4E and  5H) . These results suggest that MSCs can alter the cellular profile within a MI area through PEDF paracrine factor, and furthermore, this cellular profile alteration can be influenced by the age-specific type PEDF expression present.
Pigment epithelium-derived factor secreted by mesenchymal stem cells stimulates cardiac fibroblast proliferation and migration in dose dependent manner
It has been reported that PEDF can induce EC and macrophage apoptosis, and inhibit the proliferation and migration of ECs and VSMCs. 11,15 -18 Our results demonstrating increased PEDF levels in the infarct region associated with decreased ECs, VSMCs, and macrophages are consistent with such reports. Additionally, increased PEDF levels in the infarct region were associated with increased fibroblast presence via an elusive underlying mechanism.
To provide further evidence that MSC-secreted PEDF can affect fibroblast populations in the infarct region, we performed a transwell co-culture experiment with CFs and MSCs. We demonstrated that CF proliferation was slower when they were cultured with young MSCs than with old MSCs. Furthermore, this inhibitory effect was markedly weaker when CFs were co-cultured with Y&Ad.PEDF group ( Figure 5A) . Moreover, CF proliferation was much slower when they were cultured with old MSCs after PEDF expression had been knocked down ( Figure 5A ). In fact, our data showed that PEDF protein alone stimulated CF proliferation under hypoxic conditions in a dose-dependent fashion ( Figure 5C ). Pigment epithelium-derived factor (200 ng/mL) significantly increased the number of CFs in S phase ( Figure 5D ), up-regulated cyclin D1 expression, and down-regulated P27 ( Figure 5E ). However, 200 ng/mL PEDF did not have a pronounced effect on CF apoptosis during hypoxia ( Figure 5F ). Additionally, we demonstrated that either old MSCs with naturally high PEDF expression, or young MSCs with overexpressed PEDF, attracted more CFs in the transwell system. In contrast, knocking down PEDF expression in old MSCs attenuated CF chemotaxis ( Figure 5B) . Furthermore, by using PEDF protein to substitute MSCs in the lower compartments of the transwell system, PEDF alone was consistently shown to be an important chemoattractant of the MSC secretome ( Figure 5G ).
Discussion
Mesenchymal stem cells isolated from adult bone marrow provide excellent biomaterial source for therapeutic stem cell development. Although the present findings and previous study demonstrated MSCs could restore cardiac function partly via cell-type differentiation potential after MI, 19 the population contributions of such cell differentiation subtypes were limited. Compelling evidence has shown that the secretion of a broad range of bioactive molecules by MSCs contributes to their cardiac repair role after ischaemic onslaught. 4 -6 In this study, we identified the paracrine factor PEDF as a significant mediator of the resultant cellular profile of the post-MI infarct region. Moreover, we demonstrated that the decline in therapeutic efficacy of old MSCs was associated with age-dependent paracrine PEDF release.
Encoded by a single gene, PEDF is a 50 kDa glycoprotein with strong conservation across phyla from fish to mammals, and is widely expressed among many tissues. 11, 15, 16 Most secreted PEDF deposit within the extracellular matrix, with cell-type-specific functions. 11, 15, 16 PEDF is known as a strong anti-angiogenic factor due to its ability to induce EC apoptosis by activation of the Fas/Fas ligand transduction cascade and p38 MAP kinas dependent cleavage of caspases 3, 8, and 9, and is inhibitive of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF)-induced EC migration and proliferation. 11, 15, 16 Conversely, it exerts antiapoptotic effects on neuronal or hepatoma cells by activating the nuclear factor-kB signaling cascade or inhibiting lysosomal Bcl-xL degradation, respectively. 15, 16, 20 It can also inhibit platelet-derived growth factor-induced VSMC proliferation and migration by blocking reactive oxygen species generation, 18 although we recently demonstrated that PEDF stimulated both proliferation and migration of retinal pigment epithelial cells in a laser-induced choroidal neovascularization model. 21 It is speculated that the elusive functions of PEDF may attribute to multiple unknown receptors, the immediate cellular state, as well as pathologic signals and factors present in the cellular microenvironment. 16 Furthermore, age-related differential PEDF expression has been observed previously, but with inconsistent results among different tissues. 22, 23 We found presently that PEDF expression in older mice MSCs was significantly greater than from young mice. Notably, our results evidenced the negative correlation between MSC-secreted PEDF quantity and therapeutic potency against MI injury. Angiogenesis is induced by MSC secretion of bioactive factors, such as VEFG, bFGF, and hepatocyte growth factor, which promote both EC and VSMC proliferation and migration. 24 Conversely, MSCs also secrete PEDF, which can potentially induce apoptosis, and inhibit EC and VSMC proliferation and migration via above-mentioned mechanisms. Compared to young MSCs, old MSCs secrete more PEDF in the infarct region. It is therefore conceivable that increased PDEF levels exert more significant biological effects resulting in an infarct region containing fewer ECs and VSMCs; hence, angiogenesis is inhibited. Moreover, CFs are key effector cells in the pathogenesis of post-MI cardiac fibrosis, and it has been shown that MSCs can attenuate CF proliferation via a paracrine mechanism resulting in an anti-fibrotic effect. 25 Our in vivo experimental results are confirmatory, demonstrating both young and old MSCs administration, compared to saline, decreased fibroblast number and fibrotic region. Furthermore, the anti-fibrotic effect of MSCs attenuated with age. Our results suggested that this phenomenon was associated with the ability of PEDF to stimulate CF proliferation. The underlying mechanism likely involves up-regulation of cyclin D1 expression and P27 down-regulation, a cyclin-dependent kinase inhibitor arresting G1. Consequently, an increased number of cells were in S phase, whereas there was no effect upon apoptosis during hypoxia. Additionally, we demonstrated PEDF stimulated CF chemotaxis in dose-dependent fashion, as previously reported. 9 Thus, our study implies that, compared to younger MSCs, older MSCs increased the fibroblast population in the infarct region at least partly due to increased PEDF secretion. After MI, damaged cardiomyocytes are removed largely by macrophages and replaced by scar tissue. 2 In the present study, regardless of which cell type received which genetic alteration of PEDF expression, the more PEDF in the infarct region, the fewer macrophages were observed. This phenomenon may be attributed to the findings of Ho et al., 17 which demonstrated that PEDF induces macrophage apoptosis and necrosis via peroxisome proliferator-activated receptor g signaling. In addition, PEDF can inhibit macrophage activation. 26 Notably, reduction in macrophage infiltration and decreased macrophage activation are associated with significantly delayed MI healing, principally due to deficient phagocytosis of injured cardiomyocytes and delayed granulation tissue formation, 27 yet another aetiology for older MSCs' decreased therapeutic efficacy. The MSC delivery route having greatest impact on prevention of remodelling post-MI has not been determined. 28 In the current study, we utilized peripheral venous injection of MSCs post-MI for the following reasons. Firstly, MSCs can be infused intravenously due to their ability to gravitate to injured regions within the myocardium, stimulated, at least in part, by stromal cell-derived factor-1/CXCR4 axis. 29, 30 Secondly, intravenous infusion remains one of the safe, convenient, clinically relevant delivery approaches in patients. 31 Thirdly, it has been reported that the plastic adherent-derived MSCs are not a homogeneous cell population, which might be contaminated by a fibroblasts, osteoblasts, and adipocytes. 4 We speculate that these cellular contaminants (which exhibit no chemotactic properties) are filtered out by the peripheral circulation. Lastly, we endeavored to assess the possible impact of PEDF on MSC chemotaxis. Our results revealed the rapid recruitment of MSCs to the MI area. Additionally, no significant difference between groups was demonstrated in the relative fluorescent intensity of the infarcted heart after infusion of GFP-labeled MSCs, suggesting that PEDF has no significant impact upon MSC chemotaxis. However, there is still a huge gap between small animal models and practical clinical application, and acknowledge the limitations of this current study that do not address several major problems of stem cell-based therapy, including targeted and effective MSCs delivery route, the most appropriate time point for cell transplantation, and other risk control issues. Overall, the current study confirmed that MSCs can regulate MI pathological processes through paracrine actions. Thus, MSCs could be considered an "organizer" in the MI area, manipulating tissue cellular profile by secreting various growth factors and cytokines. We demonstrated that PEDF was one of the most important Figure 6 Schematic illustrating mesenchymal stem cells can regulate the cellular profile in the myocardial infarction area via paracrine factor pigment epithelium-derived factor. Older mesenchymal stem cells express and secrete more pigment epithelium-derived factor in infarct region than young mesenchymal stem cells, leading to fewer endothelial cells, vascular smooth muscle cells, and macrophages, but more fibroblasts in the infarct region after older mesenchymal stem cell administration. (Biological effects of pigment epithelium-derived factor upon endothelial cells, vascular smooth muscle cells, macrophages, and fibroblasts mentioned in schematic are based on present study results and previous literatures).
Expression of pigment epithelium-derived factor in aged mesenchymal stem cells factors involved in MSC paracrine function. Pigment epitheliumderived factor secreted by MSCs can act upon several cell types in the infarct region ( Figure 6 ). However, our experiments were not designed to address all discrepancies in the paracrine profile between young and older MSCs. Further experiments defining the exact alteration of the aged MSCs paracrine profile are clearly necessary. One method for increasing injury repair efficiency, and minimizing undesirable outcomes, would be directly manipulating the cell types controlling the pathological processes at work. 32 Therefore, our results imply that the most efficacious aged-donor MSC utilization must focus upon optimizing paracrine profile to favorably manipulate the cellular profile in the infarct region. For such means, our study supports PEDF as a promising novel genetic modification target for augmenting aged MSC therapeutic efficacy.
Supplementary material
Supplementary material is available at European Heart Journal online.
Conflict for interest: none declared.
